The US Food and Drug Administration (FDA) cleared Moderna to speed up vaccine output by letting it fill a single vial with up to 15 doses

The vaccine was also effective in South Africa, where B.1.351 lineage of the virus is prevalent. It said nine cases of COVID-19 were observed in the country, all in the placebo group.

A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing of its recently approved vaccine -- did not meet quality standards, J&J said on Wednesday

India close to becoming 2nd largest COVID-19 infected nationIndia is closing in on Brazil to become the second country after the US in terms of total number of COVID-19 cases in the world. Total number of cases in India has reached 12,148,487 cases as of yesterday, whereas Brazil is still ahead with 12,664,058 cases. While Brazil had 86,704 new cases, that in India was 53,158. While Brazil has a population of only 21.36 crore, that in India is 139 crore.New COVID-19 wave hits hospitality se...

The Board of Directors of GlaxoSmithKline Pharmaceuticals approved the sale of the manufacturing facility

The risk of infection fell 90% by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found

This move to further revise the prices will go a long way in helping patients during these critical times, the company said.

Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery

Stock Market News Update Today: UltraTech Cement, Titan Company, ICICI Bank, IndusInd Bank, Axis Bank were among top gainers, while ONGC, Power Grid Corporation of India, ITC, NTPC, HDFC were among top losers

The early findings from the US study are just one set of information AstraZeneca must submit to the Food and Drug Administration

The Biden administration has come under pressure from countries around the world to share vaccines, particularly its stock of AstraZeneca's vaccine, which is authorized for use elsewhere but not yet in the United States

The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States

The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray

Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator

The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death

The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US

The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech

Johnson & Johnson's single-dose COVID-19 vaccine effective, safe: FDA Drug maker Johnson & Johnson's single-shot COVID-19 vaccine is safe and effective as per the data submitted from its ongoing multi-national Phase 3 randomised, double-blind and placebo-controlled trials. This is what a  briefing document published by the US Food and Drug Administration (FDA) has said. Johnson & Johnson had sought emergency use authorisation for its vaccine on February 4. FDA's advisory co...

The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilised variant of the SARS-CoV-2 S protein.